doi: 10.1161/hy0202.104376
(Hypertension. 2002;39:710.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
Blood Pressure Variability and Organ Damage in a General Population
Results from the PAMELA Study
From Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie (R.S., M.B., L.B., G.G., G.M.), and Centro Studi di Patologia Cronico Degenerativa (M.F.), University of Milano-Bicocca, Ospedale S. Gerardo, Monza; Cattedra di Epidemiologia, Dipartimento di Statistica (G.C., R.F.), University of Milano-Bicocca and Istituto Auxologico Italiano (G.G., G.M.), Milan, Italy.
Correspondence to Prof Giuseppe Mancia, Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Donizetti 106 20052, Monza (MI), Italy.
In hypertensive patients, 24-hour blood pressure (BP) variability (V) shows a positive relationship with organ damage, organ damage progression, and cardiovascular morbidity. The clinical relevance of BPV in the population has never been investigated. In a sample of 3200 individuals, randomly selected from the general population of Monza (Milan, Italy), we evaluated BP by an automatic oscillometric device every 20 minutes for 24 hours and left ventricular mass index (LVMI) by echocardiography. In each subject, individual systolic and diastolic BP readings were averaged to obtain a 24-hour mean. Systolic BPV was obtained by calculating (1) the standard deviation of the 24-hour mean, which was taken as the overall BPV, (2) the cyclic components (Fourier spectral analysis) that in the population as a whole explained >95% of the overall BPV, and (3) the fraction of the overall BPV that in each subject was not accounted for by the 2 cyclic components, termed individual residual BPV. A similar procedure was used for diastolic BP and heart rate. Participation rate was 64.1%. Patients receiving antihypertensive therapy (n=403) were excluded from the analysis, which was therefore limited to 1648 participants. In the population as a whole, LVMI significantly related to 24-hour systolic and diastolic BP mean (ß=0.40 and ß=0.37, respectively, P<0.001 for both) but not to the 2 cyclic components that accounted for most of the BPV. On the other hand, the individual residual BPV (which accounts on average for about 50% of overall BPV) showed a significant positive relationship with LVMI (ß =0.38 and ß=0.88 for systolic and diastolic BP, respectively, P<0.05 and P<0.01). No relationship was found between LVMI and heart rate values. These findings provide evidence that there is a relationship between LVMI and 24-hour average BP values in the population. They also provide the first demonstration that in the population there is also a positive independent association between LVMI and BPV. This association, however, can be exclusively seen with the BPV component that has an erratic rather than a cyclic nature.
Key Words: blood pressure • blood pressure monitoring, ambulatory • blood pressure determination • ventricular function, left
This article has been cited by other articles:
 |
|
 |
|
  H. Kudo, H. Kai, H. Kajimoto, M. Koga, N. Takayama, T. Mori, A. Ikeda, S. Yasuoka, T. Anegawa, H. Mifune, et al. Exaggerated Blood Pressure Variability Superimposed on Hypertension Aggravates Cardiac Remodeling in Rats via Angiotensin II System-Mediated Chronic Inflammation Hypertension, October 1, 2009; 54(4): 832 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, M. Gerhardsson de Verdier, M. Dahlback, C. Janson, and L. Lind BP Variability and Cardiovascular Autonomic Function in Relation to Forced Expiratory Volume: A Population-Based Study Chest, July 1, 2009; 136(1): 177 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Kirkness, R. L. Burr, and P. H. Mitchell Intracranial and Blood Pressure Variability and Long-Term Outcome After Aneurysmal Sub-arachnoid Hemorrhage Am. J. Crit. Care., May 1, 2009; 18(3): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Parving, B. M. Brenner, John. J. V. McMurray, D. de Zeeuw, S. M. Haffner, S. D. Solomon, N. Chaturvedi, M. Ghadanfar, N. Weissbach, Z. Xiang, et al. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1663 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Phillips and J. G. Twombly Will Running the Numbers First Violate the Principles of Patient-Centered Care? Ann Intern Med, December 2, 2008; 149(11): 840 - 841. [Full Text] [PDF]
|
|
|
|
|
|
G. Parati and G. Bilo Clinical Relevance of Day-by-Day Blood Pressure and Heart Rate Variability: New Information From Home Self-Measurements Hypertension, December 1, 2008; 52(6): 1006 - 1008. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kostapanos, H. J. Milionis, and M. S. Elisaf An Overview of the Extra-Lipid Effects of Rosuvastatin Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 157 - 174. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Desjardins, I. Lobysheva, M. Pelat, B. Gallez, O. Feron, C. Dessy, and J.-L. Balligand Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis Cardiovasc Res, August 1, 2008; 79(3): 527 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Desjardins, B. Sekkali, W. Verreth, M. Pelat, D. De Keyzer, A. Mertens, G. Smith, M.-C. Herregods, P. Holvoet, and J.-L. Balligand Rosuvastatin increases vascular endothelial PPAR{gamma} expression and corrects blood pressure variability in obese dyslipidaemic mice Eur. Heart J., January 1, 2008; 29(1): 128 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ayer, V. Antic, A. G. Dulloo, B. N. Van Vliet, and J.-P. Montani Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1265 - H1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tatasciore, G. Renda, M. Zimarino, M. Soccio, G. Bilo, G. Parati, G. Schillaci, and R. De Caterina Awake Systolic Blood Pressure Variability Correlates With Target-Organ Damage in Hypertensive Subjects Hypertension, August 1, 2007; 50(2): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia, M. Bombelli, R. Facchetti, F. Madotto, G. Corrao, F. Q. Trevano, G. Grassi, and R. Sega Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study Hypertension, June 1, 2007; 49(6): 1265 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Langager, B. E. Hammerberg, D. L. Rotella, and H. M. Stauss Very low-frequency blood pressure variability depends on voltage-gated L-type Ca2+ channels in conscious rats Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1321 - H1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mancia, F. Scopelliti, and G. Grassi Hypertension and the Heart. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 198 - 202. [Abstract] [PDF]
|
|
|
|
|
|
K. Kario Morning Surge and Variability in Blood Pressure: A New Therapeutic Target? Hypertension, April 1, 2005; 45(4): 485 - 486. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Verreth, D. De Keyzer, M. Pelat, P. Verhamme, J. Ganame, J. K. Bielicki, A. Mertens, R. Quarck, N. Benhabiles, G. Marguerie, et al. Weight Loss-Associated Induction of Peroxisome Proliferator-Activated Receptor-{alpha} and Peroxisome Proliferator-Activated Receptor-{gamma} Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice Circulation, November 16, 2004; 110(20): 3259 - 3269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kuznetsova, J. A. Staessen, L. Thijs, C. Kunath, A. Olszanecka, A. Ryabikov, V. Tikhonoff, K. Stolarz, G. Bianchi, E. Casiglia, et al. Left Ventricular Mass in Relation to Genetic Variation in Angiotensin II Receptors, Renin System Genes, and Sodium Excretion Circulation, October 26, 2004; 110(17): 2644 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. T. Uusitalo, T. Laitinen, S. B. Vaisanen, E. Lansimies, and R. Rauramaa Physical training and heart rate and blood pressure variability: a 5-yr randomized trial Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1821 - H1826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Amin, J. L. Carroll, J. L. Jeffries, C. Grone, J. A. Bean, B. Chini, R. Bokulic, and S. R. Daniels Twenty-four-hour Ambulatory Blood Pressure in Children with Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 950 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pelat, C. Dessy, P. Massion, J.-P. Desager, O. Feron, and J.-L. Balligand Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide-Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E-/- Mice In Vivo Circulation, May 20, 2003; 107(19): 2480 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Prattichizzo, F. Galetta, G. Mancia, and R. Sega New Way to Express Ambulatory Blood Pressure Variability * Response: How to Measure Blood Pressure Variability Hypertension, October 1, 2002; e7(4): . [Full Text] [PDF]
|
|